- Home
- MREO vs METCB Comparison
MREO vs METCB Comparison
Compare MREO & METCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- METCB
- Stock Information
- Founded
- MREO 2015
- METCB 2015
- Country
- MREO United Kingdom
- METCB United States
- Employees
- MREO N/A
- METCB N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- METCB Coal Mining
- Sector
- MREO Health Care
- METCB Energy
- Exchange
- MREO Nasdaq
- METCB Nasdaq
- Market Cap
- MREO 424.5M
- METCB 468.8M
- IPO Year
- MREO N/A
- METCB N/A
- Fundamental
- Price
- MREO $2.41
- METCB $8.81
- Analyst Decision
- MREO Strong Buy
- METCB Strong Buy
- Analyst Count
- MREO 7
- METCB 3
- Target Price
- MREO $7.71
- METCB $15.67
- AVG Volume (30 Days)
- MREO 1.5M
- METCB 46.2K
- Earning Date
- MREO 05-19-2025
- METCB 05-12-2025
- Dividend Yield
- MREO N/A
- METCB 10.33%
- EPS Growth
- MREO N/A
- METCB N/A
- EPS
- MREO N/A
- METCB 0.21
- Revenue
- MREO N/A
- METCB $666,295,000.00
- Revenue This Year
- MREO N/A
- METCB $4.87
- Revenue Next Year
- MREO $56.11
- METCB $20.29
- P/E Ratio
- MREO N/A
- METCB $43.77
- Revenue Growth
- MREO N/A
- METCB N/A
- 52 Week Low
- MREO $1.58
- METCB $6.01
- 52 Week High
- MREO $5.02
- METCB $12.18
- Technical
- Relative Strength Index (RSI)
- MREO 50.36
- METCB 57.80
- Support Level
- MREO $2.28
- METCB $8.20
- Resistance Level
- MREO $2.75
- METCB $8.85
- Average True Range (ATR)
- MREO 0.16
- METCB 0.44
- MACD
- MREO -0.00
- METCB 0.01
- Stochastic Oscillator
- MREO 27.66
- METCB 61.70
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About METCB Ramaco Resources Inc. Class B
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.